{"paper_id": "b68b33a00c4edb2fce0f22eac3dbcd7495476134", "metadata": {"title": "The Human Gene Map", "authors": [{"first": "", "middle": [], "last": "Victor A", "suffix": "", "affiliation": {}, "email": ""}, {"first": "M", "middle": ["D"], "last": "Mckusick", "suffix": "", "affiliation": {}, "email": ""}, {"first": "", "middle": [], "last": "The", "suffix": "", "affiliation": {}, "email": ""}, {"first": "", "middle": [], "last": "Hopkins", "suffix": "", "affiliation": {}, "email": ""}, {"first": "", "middle": [], "last": "Baltimore", "suffix": "", "affiliation": {}, "email": ""}]}, "abstract": [], "body_text": [{"text": "New Haven ( 1 9 7 3 ) 3 1", "cite_spans": [], "ref_spans": [], "section": "Confirmed"}, {"text": "Rotterdam ( 1 9 7 4 ) 48 Baltimore ( 1 9 7 5 ) 7 2", "cite_spans": [], "ref_spans": [], "section": "Confirmed"}, {"text": "Winnipeg ( 1 9 7 7 ) 8 3", "cite_spans": [], "ref_spans": [], "section": "Confirmed"}, {"text": "Edinburgh ( 1 9 7 9 ) 1 2 3", "cite_spans": [], "ref_spans": [], "section": "Confirmed"}, {"text": "Oslo ( 1 9 8 1 ) 1 8 0 Los Angeles. ( 1 9 8 3 ) 247 NOV. 10, 1 9 8 4 295 1 3 . Chchromosomal change associated with particular phenotype and not proved to represent linkage (Fc), deletion (0) or virus effect (V): e.g.. loss of 1 3 q 1 4 band in Some cases of retinobiastoma. (\"Fragile sites,\" observed in cultured cells with or without folate-deficient medium or BrdV treatment, fall into this class of method, e.g., fragile site at x q 2 7 in one form of X-linked mental retardation. Fragile sites are useful as markers in family linkage studies, e.g., ~S 1 6 q 2 2 and haptoglobin.) 1 4 . OTovarian teratoma (centromere mapping), e.g., PGM3 and centromere of chr. 6 . 15. EMexclusion mapping, i.e., narrowing the possible location of loci by exclusion of parts of the map by deletion mapping, extended to include negative lod scores from families with marker chromosomes and negative lod scores with other assigned loci: e.g., support for assignment of MNSS to 4q.", "cite_spans": [], "ref_spans": [], "section": "Confirmed"}, {"text": "16. Hbased on presumed homology: e.g., assignment of LDHC to 12p. has been graded into the following classes: C = confirmedobserved in at least two laboratories or in several families (not used in the following lists but can", "cite_spans": [], "ref_spans": [], "section": "Confirmed"}, {"text": "The certainty with which assignment of loci to chromosomes or the linkage between two loci has been established be assumed when one of the other symbols is not given). P = provisionalbased on evidence from one laboratory or one family. I = inconsistentresults of different laboratories disagree. L = limbo groupevidence not as strong as provisional, but included for heuristic reasons. (Same as \"tentative\" in other terminology.)", "cite_spans": [], "ref_spans": [], "section": "Confirmed"}, {"text": "The five digit numbers given here are entry numbers in McKusick's Mendelian Inheritance in Man (6th ed., 1 9 8 3 , Johns Hopkins Univ. Press) with additions. Documentation on linkages and assignments is referenced in the entries indicated. The banding numerology is that of the Paris Conference ( 1 9 7 1 ) with the 1 9 7 5 Supplement (updated in the 1 9 7 8 report of the Standing Committee on Human Cytogenetic Nomenclature, BD: OAS XIV ( 8 ) : 1 -9 2 , 1 9 7 8 and Cytogenet. Cell Genet. 2 1~3 1 3 -4 0 4 , 1 9 7 8 ) . Also see Yunis, Science 1 9 1 : 1 2 6 8 , 1 9 7 6 : Francke and Oliver, Hum. Genet. 45: 137-165, 1 9 7 8 . For report on high-resolution banding, see ISCN ( 1 9 8 1 ) : BD: OAS XVII ( 5 ) : 1 -3 2 , 1 9 8 1 and Cytogenet. cell Genet.", "cite_spans": [], "ref_spans": [], "section": "Confirmed"}, {"text": "-31:5-32, 1 9 8 1 .", "cite_spans": [], "ref_spans": [], "section": "Confirmed"}, {"text": "-- These symbols conform, for the most part, to those recommended by the committee on Standardized Human Gene Nomenclature chaired by T. B. Shows, P. J. McAlpine, and 0. J. Miller (HGM-7, Los Angeles, 1983 ). The rules include: 1. Only caps, except in blood group symbols . 2. NO hyphens, except in HLA. 3 . No more than 4 O K 5 letters or numbers. 4. Chromosome number in symbols Only for DNA segments, e.g., D14S1. S= segment. The last number refers to sequence of delineation on particular chromsome. (Only a few DNA segments that have been mapped are shown, for illustrative purposes.) soluble) isozyme = \"1,' mitochondrial isozyme = \"2. ' 6. only arabic numbers, e.g.: SOD I = SOD1. 7. Cell surface antigens symbolized \" S \" followed by sequential number (in order of delineation): e.g., s7. see H G M~ for a list of these. mOSt of which are not specifically listed here. use PS and a number after the regular symbol to designate pseudogenes. (In addition to \"anonymous,\" i.e. function unknown, DNA segments and cell surface antigens, some peptides identified by O'Farrell 2-D electrophoresis and some antigens identifed by monoclonal antibodies have been mapped. respectively, have USUally not been included here except when they have been used for the assignment of other loci. Before their distinctness is established, the initials of the name of the laboratory are incorporated into the symbol, e.g., MIC7 for seventh Imperial cancer monoclonal. See HGM7 for a full listing.) \" 2 . replaces \"s' if the DNA fragment contains repetitive sequences.", "cite_spans": [{"start": 153, "end": 205, "text": "McAlpine, and 0. J. Miller (HGM-7, Los Angeles, 1983", "ref_id": null}, {"start": 272, "end": 288, "text": ". 2. NO hyphens,", "ref_id": null}, {"start": 289, "end": 305, "text": "except in HLA. 3", "ref_id": null}, {"start": 642, "end": 643, "text": "'", "ref_id": null}], "ref_spans": [], "section": "Confirmed"}, {"text": "Perhaps we should follow the practice of mouse geneticists and Most of these, with symbols beginning P and M,", "cite_spans": [], "ref_spans": [], "section": "Cytoplasmic (cytosolic, or"}, {"text": "The location given is often the SRO (shortest region of overlap1 based on a collation of studies of chromosomal rearrangements. The location in parentheses is a shorter interval which takes gene order data into account, OK is an assignment made indirectly through linkage t o another assigned locus. A question mark precedes assignments which are inconsistent or \"in limbo.. ", "cite_spans": [], "ref_spans": [], "section": "Cytoplasmic (cytosolic, or"}, {"text": "= Adenosine deaminase complexing protein-1 -?chr. 6 ( s ) = Adenosine deaminase complexing protein-2 -2p23-2q32 ( s ) = Alcohol dehydrogenase, class 1 -4q21-qter (REa) gene cluster for alpha, beta, gamma chains = Alcohol dehydrogenase (?control of expression) -71pter-lp23 ( s ) = Alcohol dehydrogenase, class 111, or chichr. 4 ( S l = Adenosine kinase -10qll-q24 ( S , D, EM1 = Beta-adrenergic receptor -Chr. 5 ( S ) = Temperature-sensitive (AF8) complementchr. 3 ( s ) = Alpha-fetoprotein -4qll-q13 (H, A)", "cite_spans": [], "ref_spans": [], "section": "A2M"}, {"text": "= Atrial septa1 defect, secundum type (chr. 6: linked to HLA) (F) = Aspermiogenesis factor -7 1~1 3 o r lq25 (Ch) = Argininosuccinate lyase -7p21-q22 ( S ) = Alport-syndrome-like nephritisnear xcen (Fd) BRlA, BRlB, etc.= Blastogenic response to specific synthetic polypeptides ( I r homologs) -6~21.3 I F ) = Chorionic gonadotropin, alpha chain -6q12-q21 (?18pll)(REa) = Chorionic gonadotropin, beta chainchr. 19 (REa) = Chronic granulomatous disease -(Xp22: linked to Xg) (F) = Pseudocholinesterase-1 -(chr. 3; linked to TF) (F) = chromate resistance -5q35 (S) = Creatine kinase, brain type -14q32-qter (?also 1 7 ) ( S ) = Collagenase (recessive dystrophic epidermolysis bullosa)chr. 11 (S) = Chronic myeloid leukemia -22q11.3 (ch) = Charcot-Marie-Tooth disease -(lq: linked to Fy) (F) = Colton blood group (chr. 2; linked to Jk) (D, F) = Coloboma of iris -72p25.1-pter (Ch) = collagen I alpha-1 chain -17q210-4220 (S, M, A, REa) = collagen I alpha-2 chain -7q21-q22 ( s , REa, D ) = collagen I I alpha-1 chaindistal 12q (REa) = collagen 111 alpha-1 chain -2q23 (REa, A) = collagen IV alpha-I chainchr. 13 (REa) = Collagen V -1ChK. 2 ( IFG)   I FR  IFRC  IGAS  IGEP  IGFl  IGF2  I GH  IGHAl  IGHA2  IGHD  IGHE  IGHGl  IGHGZ  IGHG3  IGHG4  IGHJ  IGHM  IGHV  I GK  IGKC  IGKJ  IGKV  IGL  IGLC  IGLJ  IGLV  I HG  IL2  InLu = Hemoglobin H related mental retardation -716p ( F ) = Hemoglobin epsilon chain -llp1205-pl208 (AAS, RE) = Hemoglobin zeta chain -16pl2-pter (REa, A) = Hemoglobin zeta pseudogene -16~12-pter (REa, A) ( t e t r a h y d r o p t e r o y l -g l u t a m a t e methyltransferase) About 1600 loci are known with confidence to exist on autosomes, on the basis mainly of characteristic patterns of inheritance of alternative forms of particular traits (see Table 11 ). information is available concerning over 30% of these loci. (shortest legions of overlap) of various assignments using broken O K rearranged chromosome). in parentheses include information concerning gene order to arrive at a shorter region of assignment, or represent assignments made indirectly through linkage with an assigned locus. In addition to the loci listed here, anonymous DNA segments, antigens defined by monoclonal antibodies, surface antigens, and function-unknown protein spots have been assigned to individual autosomes, as catalogued by HGM 7.", "cite_spans": [{"start": 1134, "end": 1135, "text": "2", "ref_id": "BIBREF44"}], "ref_spans": [{"start": 1136, "end": 1321, "text": "( IFG)   I FR  IFRC  IGAS  IGEP  IGFl  IGF2  I GH  IGHAl  IGHA2  IGHD  IGHE  IGHGl  IGHGZ  IGHG3  IGHG4  IGHJ  IGHM  IGHV  I GK  IGKC  IGKJ  IGKV  IGL  IGLC  IGLJ  IGLV  I HG  IL2  InLu", "ref_id": "TABREF0"}, {"start": 1771, "end": 1779, "text": "Table 11", "ref_id": null}], "section": "A2M"}, {"text": "As indicated by the following, some mapping The regional assignments on the left represent SROS The regional assignments A.", "cite_spans": [], "ref_spans": [], "section": "A2M"}, {"text": "chromosomal assignments (see Fig. 1 (11170) *Location surmised from genetic distances considered in relation to the chiasma map of lp (see Fig. 28 ).", "cite_spans": [], "ref_spans": [{"start": 29, "end": 35, "text": "Fig. 1", "ref_id": "FIGREF4"}, {"start": 139, "end": 146, "text": "Fig. 28", "ref_id": "FIGREF6"}], "section": "A2M"}, {"text": "The order of closely linked loci (EN01 and ~PGD: of ~l l , Rh, and FUCA: of UMPK and sc: and of FY and Cae) is uncertain. *However, the following order of loosely linked segments seems established\": 6PGD. Rh, UMPX, PGM1, Amy, (17335) Chromosome NO. 5 5pter-5ql 5qll-5q13(not 5P 5P 5qll-5q2 2 5ql3 5q15-5qter 5q34 5q35 5q31-5q35", "cite_spans": [], "ref_spans": [], "section": "A2M"}, {"text": "In addition: Emetine resistance (ribosomal protein S14) (13062) S (L)Macrocytic anemia, refractory (15355) Ch (P)Beta-adrenergic receptor (109691 S (P) Glucocorticoid receptor, lymphocyte (23157) s Histocompatibility: type I1 antigens, gamma chain of (14279) S, REb 3 anonymous DNA segments (HGM 7) and 1 surface polypeptide (18561). are B and C.", "cite_spans": [{"start": 148, "end": 151, "text": "(P)", "ref_id": null}], "ref_spans": [], "section": "q"}, {"text": "NO crossover with BF (16405) Pseudo-gamma between alpha-1 and gamma-2 (Bech-sansen et al., PNAS 80:6952, 1983 : Migone et al., PNAS 81: 5811, 1984 . ", "cite_spans": [{"start": 70, "end": 109, "text": "(Bech-sansen et al., PNAS 80:6952, 1983", "ref_id": null}, {"start": 110, "end": 146, "text": ": Migone et al., PNAS 81: 5811, 1984", "ref_id": null}], "ref_spans": [], "section": "D O r W Y 6 3 / Y T 4 / D C 4 O R r 53"}, {"text": "Beta-galactosidase-2 1 1 0 9 6 8 ) S 22qll-22qter", "cite_spans": [], "ref_spans": [], "section": "22q13-22qter"}, {"text": "Oncogene SIS: simian sarcoma Virus (19004) REa (same as platelet derived growth factor)", "cite_spans": [], "ref_spans": [], "section": "22q13-22qter"}, {"text": "In addition: 7 anonymous DNA segments and 1 surface antigen (18558) (HGM 7 ) . \"Distal to the break point that creates Philadelphia chromosome. (see assemblage of X-linkage data in Race and Sanqer, Blood Groups in Man, 6th edition, 1975.)", "cite_spans": [], "ref_spans": [], "section": "22q13-22qter"}, {"text": "In addition, 77 single copy anonymous DNA segments useful in mapping and some polymorphic have been assigned to the X chromosome and many all have been mapped to a specific region of X (HGM 7, L O 8 Anqeles, 1983; Wieacker et al., E. 2. Hum. Genet. a: 265-276, 1984; Drayna et al., PNAS 81: 2838 Fig. 12 ). The X and Y chromosomes share 11 single copy DNA probes, all located on XqlZ-Xq2Z (HGM 7). BY O'Farrell 2-D electrophoresis, 7 function-unknown protein spots coded by the x chromosome have been identified (HGM 7). Also, the genes for 4 cell antigens identified by monoclonal antibodies and 2 surface antigens (e.9.. 31345) have been mapped to the X chromosome (HGM 7). At least 2 X-chromosome-specific repetitive DNAs of unknown function have been found. ", "cite_spans": [{"start": 199, "end": 213, "text": "Anqeles, 1983;", "ref_id": null}, {"start": 214, "end": 266, "text": "Wieacker et al., E. 2. Hum. Genet. a: 265-276, 1984;", "ref_id": null}, {"start": 267, "end": 295, "text": "Drayna et al., PNAS 81: 2838", "ref_id": null}, {"start": 296, "end": 303, "text": "Fig. 12", "ref_id": null}], "ref_spans": [], "section": "C ."}], "bib_entries": {"BIBREF0": {"ref_id": "b0", "title": "the linkage is stated in general terms defined as follows: very close -recombination less than 2% (NR -no recombinant observed) close -recombination 2 -6% medium -recombination 6 -22%", "authors": [], "year": null, "venue": "", "volume": "", "issn": "", "pages": "", "other_ids": {}}, "BIBREF1": {"ref_id": "b1", "title": "Kell blood group (X) locus (11090)", "authors": [{"first": "C", "middle": [], "last": "", "suffix": ""}, {"first": "F) (", "middle": [], "last": "Spence", "suffix": ""}], "year": 1984, "venue": "", "volume": "67", "issn": "", "pages": "", "other_ids": {}}, "BIBREF2": {"ref_id": "b2", "title": "Hyperreflexia (14529) 0.14, but evidence of heterogeneity", "authors": [], "year": null, "venue": "", "volume": "", "issn": "", "pages": "", "other_ids": {}}, "BIBREF3": {"ref_id": "b3", "title": "All published data, lod = 8.94 at theta Five lipoprotein-Aq loci (152001 (7v.F) complement component-6 (C6) (21705) complement component-7 (E) (21707) I(? VIF) Linked in dog, marmoset. In man, genes physically close by DNA studies (RE). Linkage supported by observation of combined deficiency", "authors": [], "year": null, "venue": "Lackmann, clin. Exp. Immun", "volume": "3", "issn": "3", "pages": "", "other_ids": {}}, "BIBREF4": {"ref_id": "b4", "title": "Ii blood group (11080) congenital cataract ( 2 1 a h ? c , F ) Epidermolysis bullosa proqressiva", "authors": [{"first": "E B", "middle": [], "last": "R~", "suffix": ""}], "year": null, "venue": "", "volume": "", "issn": "", "pages": "", "other_ids": {}}, "BIBREF5": {"ref_id": "b5", "title": "Red hair (26630) cerebellar ataxia, a recessive form (213201 From homology to tyrosinase-Tyrosinase-negative albinism (20310) l ( l c , F ) negative albinism in the mouse", "authors": [{"first": "\u00d5", "middle": [], "last": "", "suffix": ""}], "year": null, "venue": "Cr F)", "volume": "", "issn": "", "pages": "", "other_ids": {}}, "BIBREF6": {"ref_id": "b6", "title": "Marinesco-Sjogren syndrome (24880) Hypergonadotropic hypogonadism (23L'ZI.(mr~) Lod score more than +30", "authors": [], "year": null, "venue": "", "volume": "", "issn": "", "pages": "", "other_ids": {}}, "BIBREF7": {"ref_id": "b7", "title": "In addition, the ChrOmGSOmal location of the GPTl linkage group is not completely certain with assignment claimed particularly for chromosomes 8 and 16 but also for chromosome 10 and very weakly for chromosome 13 (HGM7)", "authors": [], "year": null, "venue": "", "volume": "", "issn": "", "pages": "", "other_ids": {}}, "BIBREF8": {"ref_id": "b8", "title": "VMDl (15384) -5cM from GPTl Epidermolysis bullosa, Ogna type, EBSl (13195) -closely linked to GPTl (Linkage of breast cancer, 11448, to GPTl is unsubstantiated and perhaps disproved", "authors": [{"first": "", "middle": [], "last": "Macular", "suffix": ""}], "year": null, "venue": "", "volume": "", "issn": "", "pages": "", "other_ids": {}}, "BIBREF9": {"ref_id": "b9", "title": "A Source Book for Linkage in Man", "authors": [{"first": "B", "middle": ["J B"], "last": "Keats", "suffix": ""}, {"first": "N", "middle": ["E"], "last": "Morton", "suffix": ""}, {"first": "C", "middle": ["C"], "last": "Rao", "suffix": ""}, {"first": "Williams", "middle": [], "last": "", "suffix": ""}, {"first": "W", "middle": ["R"], "last": "Keats", "suffix": ""}, {"first": "B", "middle": ["J"], "last": "B ; &amp; E", "suffix": ""}, {"first": "", "middle": [], "last": "Honolulu", "suffix": ""}], "year": 1979, "venue": "Hum. Genet", "volume": "", "issn": "1", "pages": "145--175", "other_ids": {}}, "BIBREF10": {"ref_id": "b10", "title": "From the study of variant Y chromosomes, a factor (or factors) which determines the differentiation of the indifferent gonads into testes is known to be located on the Y chromosome, probably on the Short arm; this may be called testis determining factor (TDF). (see Davis", "authors": [{"first": "A", "middle": [], "last": "Page", "suffix": ""}], "year": 1981, "venue": "E. J. Hum. Genet", "volume": "136", "issn": "", "pages": "", "other_ids": {}}, "BIBREF11": {"ref_id": "b11", "title": "1972) and are now known also in the rat, guinea pig, and many other species. Their existence in man was first shown by the fact that mouse antisera react with human male lymphocytes but not with female lymphocytes", "authors": [{"first": "B", "middle": [], "last": "Eichwald", "suffix": ""}, {"first": "E", "middle": ["J"], "last": "Silmser", "suffix": ""}, {"first": "C", "middle": ["R"], "last": "Gasser", "suffix": ""}, {"first": "D", "middle": ["L"], "last": "Silver", "suffix": ""}, {"first": "W", "middle": ["K"], "last": "Wachtel", "suffix": ""}, {"first": "S", "middle": ["S"], "last": "Koo", "suffix": ""}, {"first": "G", "middle": ["C"], "last": "Zuckerman", "suffix": ""}, {"first": "E", "middle": ["E"], "last": "Hammerling", "suffix": ""}, {"first": "U", "middle": [], "last": "Scheid", "suffix": ""}, {"first": "M", "middle": ["P"], "last": "Boyse", "suffix": ""}, {"first": "E", "middle": ["A"], "last": "", "suffix": ""}], "year": 1955, "venue": "Serological cross reactivity between H-Y (male) antigens of mouse and man", "volume": "2", "issn": "", "pages": "1215--1218", "other_ids": {}}, "BIBREF12": {"ref_id": "b12", "title": "See also Wachtel et al., New Eng. J. s. 295: 750, 1976. H-Y and TDF may be one and the same. Like HLA, H-y is a differentiation antigen. (See Wachtel: Where is the H-Y Structural gene? cell 2 2 : 3-4. 1980.) Work by Ohno using recombinant DNA probes for H-Y Suggests that the Y-linked locus is regulatory", "authors": [], "year": 1975, "venue": "The strong likelihood that the locus that determines heterogametic sex determination and that for the H-Y antigen are one and the same was suggested by Wachtel et", "volume": "293", "issn": "", "pages": "", "other_ids": {}}, "BIBREF13": {"ref_id": "b13", "title": "The existence.of factors controlling spermatogenesis on the nonfluorescent part of the long arm of Y (distal part of Yqlll was suggested by study of 6 men with deletion of this segment and azoospermia", "authors": [{"first": "C", "middle": [], "last": "Tiepolo", "suffix": ""}, {"first": "L", "middle": [], "last": "Zuffardi", "suffix": ""}, {"first": "O", "middle": [], "last": "", "suffix": ""}], "year": 1976, "venue": "This has been called azoospermia third factor", "volume": "34", "issn": "", "pages": "", "other_ids": {}}, "BIBREF14": {"ref_id": "b14", "title": "XY and XYY genotypes; that the effect of the Y chromosome on stature is mediated through a mechanism other than androgen is suggested by the tall stature of persons with XY gonadal dysgenesis (30610)", "authors": [{"first": "J", "middle": ["M"], "last": "Tanner", "suffix": ""}, {"first": "A", "middle": [], "last": "Prader", "suffix": ""}, {"first": "H", "middle": [], "last": "Habich", "suffix": ""}, {"first": "M", "middle": ["A"], "last": "Ferguson-Smith", "suffix": ""}, {"first": "", "middle": [], "last": "Yamada", "suffix": ""}], "year": 1959, "venue": "The postulated locus is symbolized STA", "volume": "11", "issn": "", "pages": "268--270", "other_ids": {}}, "BIBREF15": {"ref_id": "b15", "title": "GMC-5, Edinburgh, 1979) suggested, on the basis of tooth size in males of various Y chromosome constitutions, that a Y-chromosomal gene controlling tooth size is independent of the testis-determining gene and is carried by Yqll (symbolized TS for 'tooth size\"). See Alvesalo and Portin", "authors": [{"first": "E", "middle": [], "last": "Alvesalo", "suffix": ""}, {"first": "Chapelle", "middle": [], "last": "De La", "suffix": ""}], "year": 1979, "venue": "Am. J. Hum. Genet", "volume": "43", "issn": "", "pages": "955--959", "other_ids": {}}, "BIBREF16": {"ref_id": "b16", "title": "10 single copy DNA segments mapped to the Y chromosome", "authors": [], "year": 1983, "venue": "", "volume": "", "issn": "", "pages": "", "other_ids": {}}, "BIBREF17": {"ref_id": "b17", "title": "1979) map to the heterochromatic portion of Yq and are presumably genetically inert because persons lacking these are phenotypically normal and normally fertile", "authors": [{"first": "G", "middle": [], "last": "Kunkel", "suffix": ""}, {"first": "", "middle": [], "last": "Smith", "suffix": ""}, {"first": "Biochemistry~", "middle": [], "last": "Boyer", "suffix": ""}], "year": null, "venue": "", "volume": "", "issn": "", "pages": "3343--3353", "other_ids": {}}, "BIBREF18": {"ref_id": "b18", "title": "An argininosuccinate synthetase pseudogene is on the Y", "authors": [{"first": "H", "middle": [], "last": "Daiger", "suffix": ""}], "year": 1982, "venue": "Nature", "volume": "298", "issn": "", "pages": "", "other_ids": {}}, "BIBREF19": {"ref_id": "b19", "title": "346, 1983) i.e., this is the sole known Y-specific gene product: the locus, termed MICZY, is located in the Ypter-Yql.1 segment. (See Fig. 1 of Polani", "authors": [{"first": "I", "middle": [], "last": "The", "suffix": ""}, {"first": "", "middle": [], "last": "Goodfellow", "suffix": ""}], "year": 1982, "venue": "Only structural gene confidently identified on the Y chromosome is that homologous to the X-linked gene for surface antigen MIC", "volume": "302", "issn": "", "pages": "", "other_ids": {}}, "BIBREF20": {"ref_id": "b20", "title": "Those assigned by somatic cell genetics include tyrosine aminotransferase regulator on xq (TATK, 31435), surface antigen, X-linked (SAX, 31345). temperature sensitive complement 1313651, monoamine oxidase A (313985)~ an actin gene (30002), a beta-tubulin gene (30185), ouabain sensitivity (311351 and a pseudogene for argininosuccinate synthetase (301811. (The first of these has been disputed.) The others were assigned by pedigree pattern (in the first instance, at least); confirmation by other methods, such as study of cell hybrids and mapping to the x chromosome in other mammals (Ohno's law), is available for some. In yet other instances (Lesch-Nyhan syndrome, testicular feminization, ornithine transcarbamylase deficiency, PRPP synthetase, etc.) confirmation was provided by demonstration of lyonization in cell Cultures or other material from heterozygotes. Actin genes (30002) have been identified on both the X and the Y (J.L. Mandel, Strasburg). The HRAS-2 oncogene", "authors": [], "year": 1983, "venue": "From the characteristics of x-linked inheritance and in several instances from studies of somatic cell hybrids, over 115 genetic loci have been assigned to the x chromosome", "volume": "302", "issn": "", "pages": "", "other_ids": {}}, "BIBREF21": {"ref_id": "b21", "title": "Regional assignments on the x chromosome by study of cell hybrids", "authors": [{"first": "A", "middle": [], "last": "", "suffix": ""}], "year": null, "venue": "", "volume": "", "issn": "", "pages": "", "other_ids": {}}, "BIBREF22": {"ref_id": "b22", "title": "Bracket on left indicate that assignment is by method other than cell hybridization: linkage, in situ hybridization or observation of X-linked disorder", "authors": [], "year": null, "venue": "", "volume": "", "issn": "", "pages": "", "other_ids": {}}, "BIBREF23": {"ref_id": "b23", "title": "Xg blood group (31470) F Steroid sulfatase (ichthyosis) (30810) F Cell surface antigen defined by monoclonal antibody, MIC2X (31347) Aicardi syndrome (30405) Ch", "authors": [], "year": null, "venue": "", "volume": "", "issn": "", "pages": "", "other_ids": {}}, "BIBREF24": {"ref_id": "b24", "title": "Hypomagnesemia, x-linked primary (30760) Ch (?balanced translocation) Chondrodysplasia punctata, X-linked (30295) Ch Gonadal dysgenesis", "authors": [], "year": null, "venue": "XY female type", "volume": "", "issn": "", "pages": "", "other_ids": {}}, "BIBREF26": {"ref_id": "b26", "title": "Polymorphic lambda RC8 probe (DxS9) about 10 CM from DMD, 15cM from RS, linked to Duchenne muscular dystrophy (31020) Ch, F Ornithine transcarbamylase", "authors": [], "year": null, "venue": "", "volume": "", "issn": "", "pages": "", "other_ids": {}}, "BIBREF27": {"ref_id": "b27", "title": "Actin (30002) REa -?pseudogene", "authors": [], "year": null, "venue": "", "volume": "", "issn": "", "pages": "", "other_ids": {}}, "BIBREF28": {"ref_id": "b28", "title": "Fd Polymorphic DNA probe L1.28 (DXS7) about 15 CM from BMD (proximal to Menkes) Testicular feminization (31370) S Retinitis pigmentosa, x-linked (312601 Fd X chromosome controlling element (X-inactivation center) (31467) Aarskog-Scott syndrome (30540) ch (balanced translocation) Anhldrotic ectodermal dysplasia (30510) Ch (balanced translocation) Sideroblastic anemia (30130) Ch (somatic cell chromosome rearrangement) Phosphoglycerate kinase (PGK) (31180) Monoamine oxidase A", "authors": [], "year": null, "venue": "", "volume": "", "issn": "", "pages": "", "other_ids": {}}, "BIBREF29": {"ref_id": "b29", "title": "L M a y be the same (see II,B for reference to structural H-Y locus on xp", "authors": [], "year": null, "venue": "", "volume": "", "issn": "", "pages": "", "other_ids": {}}, "BIBREF31": {"ref_id": "b31", "title": "Becker muscular dystrophy (31010) Fd, ?Ch (?allelic to Menkes syndrome (30940) Fd, Fc, H (close to Tfm 6 Pgk-1 x422 Alpha-galactosidase A (Fabry disease) (30150) Xq22-Xq26 Phosphoribosylpyrophosphate synthetase", "authors": [], "year": null, "venue": "", "volume": "", "issn": "", "pages": "", "other_ids": {}}, "BIBREF32": {"ref_id": "b32", "title": "* -about 35 cM from FS rXq26-Xq27 Hunter syndrome (mucopolysaccharidosis 11) (30990) Ch (balanced translocation) near HPRT(Xq13-Xq27) Temperature sensitivity, mouse and hamster, complement", "authors": [{"first": "", "middle": [], "last": "Hypoxanthine-Guanine Phosphoribosyltransferase", "suffix": ""}], "year": null, "venue": "", "volume": "2", "issn": "", "pages": "", "other_ids": {}}, "BIBREF33": {"ref_id": "b33", "title": "Xq27(distal to HPRT) Hemophilia B (factor IX) (30690) REa, A , F, D -proximal but very close FS xq27.3 Fragile site Xq27.3 (at interface between xq27 and Xq28)(30955)* xq28 Glucose-6-phosphate dehydrogenase", "authors": [], "year": null, "venue": "", "volume": "6", "issn": "", "pages": "", "other_ids": {}}, "BIBREF35": {"ref_id": "b35", "title": "Radiation-induced segregation (Goss-Harris) supports order", "authors": [], "year": null, "venue": "", "volume": "", "issn": "", "pages": "", "other_ids": {}}, "BIBREF36": {"ref_id": "b36", "title": "Regional mapping by family linkage studies (exclusive of RFLPs)", "authors": [{"first": "B", "middle": [], "last": "", "suffix": ""}], "year": null, "venue": "", "volume": "", "issn": "", "pages": "", "other_ids": {}}, "BIBREF37": {"ref_id": "b37", "title": "The Xg cluster (linkages to xq)", "authors": [], "year": null, "venue": "", "volume": "", "issn": "", "pages": "", "other_ids": {}}, "BIBREF38": {"ref_id": "b38", "title": "Xg (31470)** chronic granulomatous disease (30640) -C* Xk (31485) -V ?same locus", "authors": [], "year": null, "venue": "", "volume": "", "issn": "", "pages": "", "other_ids": {}}, "BIBREF39": {"ref_id": "b39", "title": "Nettleship-Falls type", "authors": [], "year": null, "venue": "", "volume": "", "issn": "", "pages": "", "other_ids": {}}, "BIBREF40": {"ref_id": "b40", "title": "Ocular albinism, FOrSiUS-Eriksson type (30060) -m Retinoschisis", "authors": [], "year": null, "venue": "", "volume": "", "issn": "", "pages": "", "other_ids": {}}, "BIBREF42": {"ref_id": "b42", "title": "HGM61 suggested order: xg -STS -Xk -cen", "authors": [{"first": "", "middle": [], "last": "&apos;*ropers", "suffix": ""}], "year": null, "venue": "", "volume": "", "issn": "", "pages": "", "other_ids": {}}, "BIBREF43": {"ref_id": "b43", "title": "HGMK) suggested order: STS -llcM -Xg -12cM -Xk -OA", "authors": [{"first": "", "middle": [], "last": "Ferquson-Smith", "suffix": ""}], "year": null, "venue": "", "volume": "", "issn": "", "pages": "", "other_ids": {}}, "BIBREF44": {"ref_id": "b44", "title": "The G6PD cluster (linkages to G6PD unless otherwise indicated) xq28", "authors": [], "year": null, "venue": "", "volume": "", "issn": "", "pages": "", "other_ids": {}}, "BIBREF45": {"ref_id": "b45", "title": "Glucose-6-phosphate dehydrogenase (30590) -about 6cM from FS Deutan colorblindness (30380) -c (order: HPR~-deutan-G6PD-protan", "authors": [], "year": null, "venue": "", "volume": "", "issn": "", "pages": "", "other_ids": {}}, "BIBREF50": {"ref_id": "b50", "title": "Hunter syndrome (30990) -m ( ? linked to xm)--consonant with translocation datum Xm (31490) -m", "authors": [], "year": null, "venue": "", "volume": "", "issn": "", "pages": "", "other_ids": {}}, "BIBREF51": {"ref_id": "b51", "title": "Mental retardation with large testes and fragile site (30955) (Linkage to G6PD or colorblindness has been demonstrated: in turn linked closely to HEME but HEMB not linked to the G6PD cluster. Recombination hotspot at FS suggested by lack of linkage of", "authors": [], "year": null, "venue": "", "volume": "", "issn": "", "pages": "", "other_ids": {}}, "BIBREF52": {"ref_id": "b52", "title": "For methodologic and interpretive discussions of the human gene map, see the following references", "authors": [], "year": null, "venue": "", "volume": "", "issn": "", "pages": "", "other_ids": {}}, "BIBREF53": {"ref_id": "b53", "title": "Somatic cell genetics and gene mapping", "authors": [{"first": "F.-T", "middle": [], "last": "Kao", "suffix": ""}], "year": 1983, "venue": "Int. Rev. cytol", "volume": "85", "issn": "", "pages": "109--146", "other_ids": {}}, "BIBREF54": {"ref_id": "b54", "title": "The status of the gene map of the human chromosomes", "authors": [{"first": "V", "middle": ["A"], "last": "Mckusick", "suffix": ""}, {"first": "F", "middle": ["H"], "last": "Ruddle", "suffix": ""}, {"first": "V", "middle": ["A"], "last": "Mckusick", "suffix": ""}], "year": 1977, "venue": "Wilhemine E. Key Lecture) J. Hered", "volume": "196", "issn": "", "pages": "370--391", "other_ids": {}}, "BIBREF55": {"ref_id": "b55", "title": "The human genome through the eyes of a clinical geneticist", "authors": [{"first": "V", "middle": ["A"], "last": "Mckusick", "suffix": ""}], "year": null, "venue": "Cytogenet. Cell Genet", "volume": "34", "issn": "", "pages": "7--23", "other_ids": {}}, "BIBREF56": {"ref_id": "b56", "title": "A new era in mammalian gene mapping: somatic cell genetics and recombinant DNA methodologies", "authors": [{"first": "F", "middle": ["H"], "last": "Ruddle", "suffix": ""}], "year": 1981, "venue": "Nature", "volume": "294", "issn": "", "pages": "115--120", "other_ids": {}}, "BIBREF57": {"ref_id": "b57", "title": "Mapping the human genome: cloned genes, DNA polymorphisms, and inherited disease. e", "authors": [{"first": "A", "middle": ["Y"], "last": "Sakaguchi", "suffix": ""}, {"first": "S", "middle": ["L"], "last": "Naylor", "suffix": ""}, {"first": "H", "middle": [], "last": "Land", "suffix": ""}, {"first": "L", "middle": ["F"], "last": "Parada", "suffix": ""}, {"first": "R", "middle": ["A"], "last": "Weinberg", "suffix": ""}], "year": 1982, "venue": "cellular oncogenes and multistep carcinogenesis", "volume": "12", "issn": "", "pages": "771--778", "other_ids": {}}, "BIBREF58": {"ref_id": "b58", "title": "Catalogue of chromosome aberrations in cancer", "authors": [{"first": "F", "middle": [], "last": "Mitelmann", "suffix": ""}, {"first": "J", "middle": ["J"], "last": "Yunis", "suffix": ""}], "year": 1983, "venue": "Cytogenet. cell Genet", "volume": "36", "issn": "", "pages": "227--236", "other_ids": {}}}, "ref_entries": {"FIGREF0": {"text": "enzyme fine analysis (RE1 Homology of synteny (H) Radiation induced gene segregation ( R ) Others (LD, OT, EM, V, REb, C, M, AAS) Total (many mapped by 2 or more methods)", "latex": null, "type": "figure"}, "FIGREF1": {"text": "Alpha-2-macroglobulinchr. 12 (REa) = Adenovirus-12 chromosome modification site-1C -1q42-43 ( v ) = Adenovirus-12 chromosome modification site-1A -lp36 ( v ) = Adenovirus-12 chromosome modification site-18 -lq2l ( v ) = Adenovirus-12 chromosome modification site-17 -17q21-q22 ( v ) = Beta-amino acids, renal transpoEt of -?chr. 21 (D) = Oncogene: Abelson strain of murine leukemia virus", "latex": null, "type": "figure"}, "FIGREF2": {"text": "Anterior segment mesenchymal dysqenesis (chr. 4; linked to M N S S ) (F) = Asparaginyl-tRNA synthetasechr. 18 ( m a ) = Asparaqine synthetase -7pll-qll (S) = Argininosuccinate synthetase -9q34 ( s , D) = Argininosuccinate synthetase pseudogene-2chr. 6 (REa) = Antithrombin 111 -lq23.1- \u00b623.9 (F, D, A, REa) = Tyrosinase negative albinism -(711~: linked to NAG in mouse) (H) = OMR (4.v.) = Antiviral state regulatorchr. 16 ( D ) = Antiviral state repressor cegulator -75p ( s ) = Beta-2-microglobulin -15q21-q22 (s, H ) = Beta-2-microglobulin regulator -15q13-ql5 ( D ) = BALB/C 3T3 ts2 temperature sensitivity complementing -xq13-xq27 ( s ) = Beta-adrenergic stimulation, response to -Ichr. 21 (D) = B-cell leukemia-1 -llq13 (RE) = Branched chain amino acid transferase-1 -12pter-q12 ( S ) = Branched chain amino acid transferase-2chr, 14 ( S ) = Baboon M7 virus infectionchr. 6 ( s ) = Properdin factor B -6~2 1 3 (in MHC) (F) = Biliverdin reductase -7p14-cen (S) = Oncogene BLYMl: chicken bursa1 lymphoma -lp32 ( A )", "latex": null, "type": "figure"}, "FIGREF3": {"text": "component-4 binding protein -?chr. 6 (H) = complement component-4 fastchr. 6 (in MHC) ( F ) = Complement component-4 slowchr. 6 (in MHC) (F) = Complement component-8 -Ip (F) = Carbonic anhydrase 11chr. 8 (S) = Cataract, zonular pulverulent (lcen-q21): linked to ~y ) (F) = Congenital adrenal hyperplasia-1 (21-hydroxylase deficiency) -( 6~2 1 ) (F) = cataract, anterior polar -72p25 OK 14q24 (FC) = Catalase-llpl305-pl306 (S,D) = Coxsackie B3 virus susceptibilitychr. 19 ( S ) = Colorblindness, blue monochromatic -IXq28 ( F ) = Colorblindness, deutan (Xq28) ( F ) = Colorblindness, protan (Xq28) (F) = Cystathionine beta-synthasechr. 21 (S) = Carotid body tumor -113q34 (F) = Congenital cataract -(116q; ?linked to HP) (F) = Chondrodystrophia punctata, x-linked -7xp22.32 (Ch) = cat eye syndrome -122pter-qll ( D ) = Chorionic gonadotropin (?nonstructUral locus)(?chr. 10 and 18) ( S , REb)", "latex": null, "type": "figure"}, "FIGREF4": {"text": "Chorionic somatomammotropin-like -17q210-q220 (RE) = Calcitonin -llp13-pl5 (REa,A) = Cystathionasechr. 16 ( S ) = Chymotrypsinogen Bchr. 16 (REa) = Coronavirus 229E sensitivity -15qll-qter ( S ) = Previously anonymous DNA segment found identical to SK (q.V.) = DNA segment G8 (linked to Huntington disease)chr. 4 (REa)= DNA segment -14q32 ( S )first RFLP discovered. = Polymorphic DNA segment -XpllO-pll3 (REa) = Dopamine-beta-hyroxylase -(?chr. 9: ?linked to ABO) ( F ) = l a (immune response) antigens of D C 1 specificity -6p2105-p23 (F) = Desmosterol-to-cholesterol enzymechr. 20 (F) = Diastrophic dysplasia -? chr. 1 8 (Ch) = Dentinogenesis imperfecta-1 -(chr. 4: linked to GC) (F) = DiGeorge syndrome -22qll (Ch) = Dihydrofolate reductase -5qll-q22 ( S , REa, H) = Quinoid dihydropteridine reductasechr. 4 ( S ) = Dihydrotestosterone receptor = TFM (S.V.) = NADH-diaphorase -22q1331-qter ( S ) = Diaphorase-2 -?chr. 7 ( S ) = Diaphorase-4 -16q12-q21 ( S ) = Defective interfering particle induction, control ofchr. 16 ( S ) = Dubin-Johnson syndromechr. 13 (LD) = Dyslexia-1chr. 1 5 (Fc) = Duchenne muscular dystrophy -?Xp12-p21 (Ch) = Myotonic dystrophy -(chr. 19: in group linked to C3) ( F ) = Cytoplasmic membrane DNA -9qh (H, A ) = Lysosomal DNA-asechr. 19 ( S ) = Dombrockblood group -( l p : linked to PGD) ( F ) = Diphtheria toxin sensitivity -SqlS-qter ( S ) = Echo 11 sensitivity -194 ( S ) = CLGN (q.V.1 = Epidermolysis bullosa, Ogna type (?chr. 16: linked to GPT1) (F) = Elongation factor-2chr. 1 9 t S ) = Epidermal growth factor -4q21-qter (REa) = Epidermal growth factor, receptor for -7p13-p22 ( S ) = Elliptocytosis-1 -( l p : linked to Rh) ( F ) = ~lliptocytosis-2 -(?linkage to chr. 1 markers other than Rh) (F) = Elastase-1chr. 12 ( R E a ) = Elastin -Zq31-qter (A) = Emetine resistance (ribosomal protein 514) -5q31-q35 ( S ) = Enolase-1 -lp36-pter is, F, R ) = Enolase-2 -12pll-p12 ( s ) = 0ncogene:avian erythroblastic leukemia viruschr. 17 ( S ) = oncogene ERBB -7pter-q22 (S) = Endogenous retrovirus-1chr. 1 8 ( S ) = Esterase-A4 -llq13-q22 ( S ) = Esterase activatorchr. 14 ( S ) = Esterase-83chr. 16 ( S ) = Ewing sarcoma -122q12 (or llq24) (ch) = Esterase D -13q14.1 ( S , F, D ) = Multiple eXOStoSis -(?9q3: ?linked to ABO) ( F ) = Clotting factor VII -l3q34 (D) = Clotting factor VII expression (chr. 8 ) ( D ) = clotting factor VIII, procoagulant component = HEMA (q.v.Clotting factor IX (see HEMB) -Xq27 (REa, A, F, D1 = Clotting factor X -13q34 (D) = clotting factor XII (Hageman factor) -6p23-pter (D) = Factor XIII, component A -6p22 ( F ) = F-cell production -(llp)(F) = Formaldehyde dehydrogenase -4p14-qter ( S ) = F9 embryonic antigen -( 1 6~: ?linked to HLA) (H) = Onc gene: feline sarcoma virus -15q25-q26 ( S ) = Fibrinogen, alpha chain -4q21-q31 ( R E a , H) = Fibrinogen, beta chain -4q21-q31 (REa) = Fibrinogen, gamma chain -(chr. 4: linked to MNSs) (F, REa)", "latex": null, "type": "figure"}, "FIGREF5": {"text": "Familial hypercholesterolemia -19pter-q13 (F, S) = Oncogene FMS (McDonough feline sarcoma virus) -5q34 ( S ) = Fibronectinchr. 2 ( S ) (see also chr. 8 and 11) = Oncogene FOS: FBJ osteosarcoma virus -14q21-q31 (REa, A) = Folylpolyglutamate synthetase -9cen-9q34 ( S ) = FRAGILE SITE, observed in cultured cells, with o r without folate-deficient medium, or BrdU -Ferritin heavy chainchr. 11 (REa) = Ferritin heavy chain pseudogenelp (A, REb) = Ferritin light chainchr. 19 ( S , A )= Alpha-L-fucosidase-1 -lp32-p34 ( S , F, R ) = Alpha-L-fucosidase-2 -L?chr. 4: linked to PLG) ( F ) = Alpha-L-fucosidase regulator -?closely linked to FUCAl (LD) = Polykaryocytosis inducerchr. 10 LS) = Duffy blood group -lq12-q21 (F, FC) = Acid alpha-glucosidase -17q23-q25 LS, A) = Alpha-galactosidase B -22q13-qter ( s ) = Galactose-4-epimerase -lp32-pter (S, LD) = Galactokinase -17q21-q22 ( S , C, R ) = Galactose-1-phosphate uridyltransferase -9p13-p21 (S , D, F) = Neutral alpha-glucosidase AB -llql3-qter ( S ) = Neutral alpha-glucosidase cchr. 15 ( S ) = Glyceraldehyde-3-phosphate dehydrogenase -1 2~1 3 ( S , D) = Glycinamide ribonucleotide synthetasechr. 21 ( S ) = Acid beta-glucosidaselq ( S ) = Group-specific component -4qll-ql3 (F, FC) = Growth rate controlling factor-2chr. 1 6 ( S ) = Glucagon -2p36-p37 (REa, A) = Greig craniopolysyndactyly syndrome -?3p21.1 Of 7p13 (Ch) = Gamma-glutamylcyclotransferase -7p14-pter ( S ) = Glucose dehydrogenaselpter-p36.13 ( S ) = GROWTH HORMONE/PLACENTAL LACTOGEN GENE FAMILY -17q210-4220 ( S , REa, A) = Growth hormone, normal -17q210-q220 (S, REa, A) = Goldenhar syndrome -?7p (Ch) = Growth hormone, variant -17q210-q220 ( S , REa, A) = Alpha-galactosidase A -xq22 (F, S , R ) = Galactose t activatorchi. 2 (S) = congenital glaucoma-1 -7chr. 11 (Ch) = Beta-galactosidase-1 -3p21-cen ( S ) = Beta-galactosidase-2 -22q13-qter ( S ) = Glyoxalase I -6p21.3-p21.2 (F,S) = Glycine auxotroph B, complementation of hamster -8qZl.l-qter ( S ) = GM2-ganglioside activator (HEX A activator)chr. 5 ( S )", "latex": null, "type": "figure"}, "FIGREF6": {"text": "glucuronidase modifierchr. 19 ( S ) = Temperature sensitivity, complementation of, in cell-line H142chr. 9 ( S ) = ist to compatibility antigen, class 11, gamma chainchr.5 ( S , REb) = HISTONE CLUSTER A (H1, H2A, H2B) -7q32-q36 (A) = Hydroxyacyl-CoA dehydrogenasechr. 7 ( S ) = F12 (4.V.) = Glyoxalase 11 (hydroxyacyl glutathione hydrolase)chr. 16 ( S ) = HISTONE CLUSTER B (H3, H4) -lq2 (REa,A) = Hemoglobin alpha chain -16~12-pter (HS, REa, A, D) = AG (q.V.) = Growth Kate controlling factOK-1chr. 7 ( S ) Guanylate kinase-1 L 2 -lq32-q42 ( S )", "latex": null, "type": "figure"}, "FIGREF7": {"text": "Hemoglobin beta chain -llp15 (LD, AAS, F, RE, S ) = NAG (S.V.) = Hemoglobin delta chain -llp15 (LD, AAS. F, RE, S ) = Hemoglobin gamma chain, ala as AA 136 -llp15 (AAS, RE) = Hemoglobin gamma chain, gly as AA 136 -llp15 (AAS, RE) = Hemoglobin gamma regulator -llp15 (RE)", "latex": null, "type": "figure"}, "FIGREF8": {"text": "Hemochromatosis fchr. 6; linked to RLA) (LD,F) = Bombay phenotype -(chr. 19: linked to Lutheran) (F) = Hexokinase-1 -10~11.2 ( S ) = Human leukocyte antigens, class I -6p21.3 (F, S , A) = Human leukocyte antigens DP -6p21.3 (F, A , RE, Ch) = Human leukocyte antigens DQ -6p21.3 (F, A, RE) = Human leukocyte antigens DR -6p21.3 (F, A, RE) = Human leukocyte antigens DZ -6~21.3 (RE) = Hypomagnesemia, X-linked primary -?Xp22 (ch) = Haptoglobin -16q22 (FC) = Hpa I restriction endonuclease polymorphism -llp1205-pl208 (RE) = Reterocellular hereditary persistence of fetal hemoglobin = FCP (9.v.) = Hypoxanthine-guanine p h o s p h o r i b o s y l t r a n s f e r a s e -Xq26-q27 (F, S, R ) = Harvey rat sarcoma-1 protooncogene -llp15.5-p15.1 ( S ) = Harvey rat sarcoma-2 protooncogenex chr. (REa)pseudogene = 5-Hydroxytryptamine oxygenase regulatorchr. 21 ( D ) = Herpes virus-sensitivity (?Chr. 3 and/or 11) ( S ) = Y histocompatibility antigen, locus A -Y chr. (F) = Y histocompatibility antigen, locus Bx chr. (Ch) -?regulator = Y histocompatibility antigen, locus C -?X chr. (Ch) -?receptor = Alpha-L-iduronidase -22pter-qll is) = Insulin-dependent diabetes mellitus -Ochr.6: ?linked to HLA) IF) = Isocitrate dehydrogenase, soluble -2q32-qter ( S ) = Isocitrate dehydrogenase, mitochondria1 -15q21-qter ( S ) = Interferon 1 and 2 -7chr. 2 and 5, respectively ( S ) = Interferon, fibroblast -9p24-pl3 (REa) = Interferon, immune -12q24.1 (A) = INTERFERON, LEUKOCYTE, GENE CLUSTER -9qter-pl3 (REa) = AVR (g.V.) = Interferon receptor (antiviral protein) -2lq21-qter ( S , D ) = Immunoglobulin heavy chains attachment sitechr. 2 ( S ) = I~E pseudogenechr. 9 (A) = Insulinlike growth factor Ichr. 12 (HEa) = Insulinlike growth factor I1chr. 11 (REa) = IMMUNOGLOBULIN HEAVY CHAIN GENE CLUSTER -14q32.3 ( S ) = Gene for constant region of heavy chain of IgAl -14q32 ( S , RE) = Gene for constant region of heavy chain of IgA2 -14832 ( S , RE) = Gene for constant region of heavy chain of IgD -14q32 ( S , RE) = Gene for constant region of heavy chain of IgE -14q32 ( S , RE) = Gene for constant region of heavy chain of IgGl -14q32 ( S , RE) = Gene for constant region of heavy chain of IgG2 -14q32 ( S , RE) = Gene for constant region of heavy chain of IgG3 -14q32 ( s , RE) = Gene for constant region of heavy chain of IgG4 -14q32 ( S , RE) = Gene (multiple) for J (joining) region of heavy chainchr. 14 (S, RE) = Gene for constant region of heavy chain of IgMchr. 14 ( S , RE) = Gene (multiple) for variable region of heavy chainchr. 14 ( S , RE) = IMMUNOGLOBULIN KAPPA LIGHT CHAIN GENE CLUSTER -2P (A) = Gene for constant region of kappa light chain -2p (A) = Gene (multiple) for J (joining) region of kappa light chain -2p ( A ) = Gene (multiple) for variable region of kappa light chain -2p (A) = IMMUNOGLOBULIN LAMBDA LIGHT CHAIN GENE CLUSTERchr. 22 (REa) = Gene for constant region of lambda light chainchr. 22 (REa, A ) = Gene (multiple) for J (joining) region of lambda light chainchr. 22 (REa) = Gene (multiple) for variable region of lambda light chainchr. 22 (REa) = Immune response to synthetic polypeptide -HGAL -6~2 1 . 3 (F) = TCGF (q.V.1 = Lutheran inhibitor -?linked to Rh (F) = Insulin -llp15-p15.5 ( S , A, REb) lNSL = Insulin-like DNA sequence -6p23-ql2 (REa) INTl = Oncogene INT: putative murine mammary cancer oncogene -12pter-q14 (REa)", "latex": null, "type": "figure"}, "FIGREF9": {"text": "Kirsten rat sarcoma protooncogene-2chr. 12 ( s ) = Leukocyte antigen group fivechr. 4 ( S ) = Laryngeal adductor paralysis -(Ichr. 6; ?linked to HLA) ( F ) = Leucyl-tRNA synthetasechr. 5 (S) = Lecithin-cholesterol acyltransferase -(16q22: linked to HP) (F, LD) = Lentil agglutinin bindingchr. 14 ( s ) = Lactate dehydrogenase A -llp1203-pl208 ( s ) = Lactate dehydrogenase B -12p121-pl22 ( s , D) = Lactate dehydrogenase C -(?12p; linked to LDHB in pigeon) (H) = Low density lipoprotein receptor = FHC (q.V.1 = Lewis blood group (chr. 19; linked to c3) (F) = Leu-7 membrane antigen of natural killer lymphocyteschr. 11 ( S ) = Langer-Giedion syndrome -8q23.3 (Ch) = Luteinizing hormone beta subunitchr. 19 ( R E ) = Lysosomal acid lipase-A -Chr. 10 ( S ) = Lysosomal acid lipase-Bchr. 16 ( S ) = Letterer -Siwe disease -?13q14-q31 (ch) = Lutheran blood groupchr. 19 ( F ) = LW (Landsteiner-Wiener) blood group -Chr. 19, close to C3, Lu, (F) = External membrane protein-130chr. 1 0 ( S ) = External membrane protein-195chr. 14 ( S ) = Baboon M7 virus sensitivity-1chr. 19 ( S ) = cytoplasmic alpha-D-mannosidase -15qll-qter ( S ) = Lysosomal alpha-D-mannosidase -19pter-q13 (S) = Melanoma-associated antigen p97 -Chr. 3 ( S ) = MaCrOCytiC anemia, refractory -5q (Ch) = MTRNS (g.V.) = Myoglobin -22qll-ql3 (REa) = Microcephaly, true -?lq31-q321 (Ch) = Malate dehydrogenase, soluble -2p23 ( S ) = Malate dehydrogenase, mitochondrial -Manic-depressive illness (?chr. 6 : ?linked to HLA) ( F ) = Miller-Dieker lissencephaly syndrome -1 1 7~1 3 (ch) = Malic enzyme, soluble -6q12 ( S ) = Malic enzyme, mitochondrial -Ichr. 11 (H) = Multiple endocrine neoplasia, type I1 (Sipple syndrome) -20~12.2 (Ch) = Muscle glycogen phosphorylase -llql3-qter (REb) = MAJOR HISTOCOMPATIBILITY COMPLEX -6P2105-p23 IF, S) = Attached cell antigen 28.3.7 found by Imperial Cancer monoclonalchr. 15 ( S ) = Menkes disease -Xq13, 5cM from centromere (H, F ) = Mixed lymphocyte reaction, weak (chr. 6 ) ( F ) = Malignant melanoma, cutaneous -(Ilp: ?linked to Rh) ( F ) = MN blood group -4q28-q31 (F, FC, AAS) = Onc gene: Moloney murine Sarcoma virus -8422 ( S ) = Mannosephosphate isomerase -15q22-qter ( S ) = Mucopolysaccharidosis I1 (Hunter syndrome) -Xq26-q27 (Ch) = Monkey red blood cell receptorchr. 6 ( S ) = Methylthioadenosine phosphorylase -9pter-9q12 ( S ) = 5 -M e t h y l t e t r a h y d r o f o l a t e : L-homocysteine S-methyltransferasechr. 1 ( s ) = Methioninyl-tRNA synthetasechr. 12 ( 5 ) = Onc gene: avian myeloblastosis virus -6p21-q22 ( S ) = Onc gene: myelocytomatosis virus -8q24 (A) = Myosin, cardiac, heavy chain, A (adult)l'lpll-pter (A) = Myosin, skeletal, heavy chain, B (fetal) -17pll-pter ( A ) = Myosin, skeletal, heavy chain, adult-1 -17pll-pter (REa) = Myosin, skeletal, heavy chain, adult-2 -17pll-pter (REa) = Myosin, skeletal heavy chain, embryonic-1 -17~11-pter (REa) = FIYOSIN, HEAVY CHAIN GENE FAMILY -17pll-pter (REa1 = METALLOTHIONEIN I AND I1 CLUSTERS -Chr.16 (REa)", "latex": null, "type": "figure"}, "FIGREF10": {"text": "Xp22: linked to xg) IF) = Ocular albinism-2 (Forsius-Eriksson type) -(xp22: linked to xg) ( F ) = Optic atrophy. Kjer type -Ochr. 2; ?linked to Jkl ( F ) = 2',5'-oligoisoadenylate synthetasechr. 11 ( s ) = Orotidylmonophosphate decarboxylase (with OPRT, q.v.Oligomycin resistance (mitochondria1 ATPase)chr. 10 I S Orotate p h o s p h o r i b o s y l t r a n s f e r a s e -OMP decarboxylase -3cen-q21 ( s ) = Orosomucoid -(9934: linked to ABO) (F1 = Ornithine transcarbamoylase -Xp21 (Ch) = Phenobarbital-inducible P450chr. 19 (REa) = Phenylalanine hydroxylase -12q24.1 IREa) = Phosphoribosylaminoimidazole synthetasechr. 21 ( S ) = Porphobilinogen deaminase -llq23-qter I S ) = Paget disease of bone -(?chr. 6: ?linked to HLAI IF) = Platelet derived growth factor = SIS (4.V.l = Peptidase A -18423 (S, Dl = Peptidase B -12421 IS) = Peptidase Clq ( S , R ) = Peptidase D -19pter-q13 ( S ) = Peptidase E -17q23-qter ( S ) = Peptidase S -4p12-ql2 (S) = Phosphoribosyl formylglycinamidine synthetasechr. 14 ( S ) = Phosphofructokinase, liver -21q22 ( S ) = Phosphofructokinase, musclelcen-lq32 I s ) Phosphofructokinase, plateletlopter-pll.1 I S 1 PG = Pepsinogen -?chr. 6 IF, H) PGAMl = Phosphoglycerate mutase A -10q25.3-q26.1 (D, H ) PGD = 6-Phosphogluconate dehydrogenase -lp36.13-pter (F, s ) PGFT = Phosphoribosylglycinamide formyltransferase -14q22-qter (S) PGK1PGKA;PGKl) = Phosphoglycerate kinase -Xql3 IF, S ) PGKB( PGK2) = Phosphoglycerate kinase, testicular -6p (REa, H) PGMl = Phosphoglucomutase-1 -lp22l (F, S, R ) Phosphoglucomutase-3 -6q12 I S , F, OTI PGP = Phosphoglycolate phosphatase -16p13-pl2 Is1 PI = Alpha-1-antitrypsin -14q (F,S) PKM2 = Pyruvate kinase-3 -15q22-qter (s,DI PKU = PAH 1q.V.) PL = Placental lactogen (same as CSA, CSB, q.v.) -17q210-17q220 ( s , REa, A ) PLA = Plasminogen activatorchr. 6 ( s ) PLG = Plasminogenchr. 4 (sl PLTl = Primed lymphocyte test-1 -6p2105-p23 ( F l POMC = Proopiomelanocortin -2823 (REa) PP = Inorganic pyrophosphatase -lOqll.l-q24 (S) PPAT = Phosphoribosylpyrophosphate amidotransferase -4pter-q21 ( S l PRGS = Phosphoribosylglycinamide synthetase -21q22 IS,H) PRL = Prolactin -6p23-ql2 I s ) PRPS = Phosphoribosylpyrophosphate synthetase -X chr-(F, S ) PSP = Phosphoserine phosphatase -7qter-q22 (Sl P TH = Parathyroid hormonellpter-pll (REa) PVS = Polio virus sensitivity -19q ( s ) PWS = Prader-Willi syndrome -15qll-ql2 (Chl", "latex": null, "type": "figure"}, "FIGREF11": {"text": "u 2 small nuclear -17q21 (A) = Retinitis pigmentosa-1 (?chr. 1 ) ( F ) = Ribulose 5-phosphate 3-epimerase -2q32-qter ( s ) = Ribosomal protein S14 = EMTB (q.V.) = Retinitis pigmentosa, X-linked -(XpllO-Xpll3: linked to DXS7) (Fd) = Retinoschisis -(xp22; linked to xg) (F) = Ragweed sensitivity -(chr. 6: ?linked to HLA) ( F ) = surface antigen 7 = EGFR (q.v.1 = S-adenosylhomocysteine hydrolase -20cen-20q13.1(S) = Amyloid Pchr. 1 (REa) = Scianna blood group -(lp32-p34) ( F ) = Spinocerebellar ataxia I -(chr. 6: linked to HLAI (F) = Small-cell cancer of lung -3p14-p23 (Ch, D) = Succinate dehydrogenase -1~22.1-qter ( s ) = Secretor -(chr. 19; in group linked to c3) ( F ) = Stoltzfus blood group -(4q: linked to MNSs) ( E ) = Surface antigen, glycoprotein 75,000chr. 11 ( s ) = Serine hydroxymethyltransferase -12q12-ql4 ( s ) = Oncogene: simian sarcoma viruschr. 22 (REa)-same as platelet-derived growth factor = Oncogene Sloan-Kettering chicken virus -lql2-lqter (REa) = superoxide dismutase, soluble -21q2ll ( S , D) = superoxide dismutase, mitochondrial -6q21 ( S ) = Sorbitol dehydrogenase -15pter-q21 (s, H) = Spermatogenesis factor-3 (azoospermia third factor)iyqll (D) = Surface polypeptide, anonymouschr. 2 , 5, respectively ( S ) = SALIVARY PROTEIN COMPLEX -?6p Or chr. 12 ( F ) = spherocytosis -8pll. ?14q (F, Ch) = oncogene SRC (ROUS sarcoma) -2Oq12-ql3 (REa, A ) = Oncogene SRC2 -Ip34-p36 (A) = S S blood group -4q28-931 ( E , Fc, AAS) = Somatostatin -3q27-3q28 (REa, A) = Stature -Y chr. (D) = Steroid sulfatase -Xp22.3 (F, S ) = T-cell antigen receptor, beta subunit -7q22-qter (REa, A) = T-cell growth factor (interleukin-2)chr. 4 (REa) = Transcobalamin I1 -?chr. 16 or 17 (H) = Testis determining factor -Y chr. (?same as HYA) (F) = Transferrin -3q21-q25 ( S , H) = Testicular feminization syndrome (dihydrotestosterone receptor)-xpll-q13 ( s ) = Transferrin receptorchr. 3 (s, H, REa) = Thyroglobulinchr. 8 ( s ) = Thrombocytosis, primary -21q (ch) = Thymidine kinase, soluble -17q21-q22 (S, C, R) = Thymidine kinase, mitochondrialchr. 16 ( S ) = TKCR syndrome of Goeminne -IXq28 (Ch) = Triosephosphate isomerase-1 & 2 -TPI-1 on 1 2~1 3 ( S , D) = T-cell receptor for MHC antigens -?chr. 14 ( H ) = RNTMI (S.V.) = Trypsin-1 -7q22-qter (REa) = Thymidylate synthasechr. 18 (S) = Tooth size, Y-linked -?Yqll (D) = Temperature sensitivity, complementation of, in ts13 cell-linechr. 4 ( s ) = Temperature sensitivity, complementation o f , in ts546 cell-linechr. 6 (S) = Tyrosine hydroxylasel l p (REa, A ) = Sclerotylosis -(4q; linked to MNSs) (F) Uridyl diphosphate glucose pyrophosphorylase-1 -lq21-q23 ( S , R ) = uridyl diphosphate glucose pyrophosphorylase-2chr. 2 ( S ) = Uridine monophosphate kinase -lp32 ( S , R) = Uridine phosphorylasechr. 7 ( S ) = Uroporphyrinogen I synthase = PBGD (4.v.) = Uroporphyrinoqen decarboxylasechr. 1 ( S ) = Ultra-violet damage repairchr. 13 ( S ) = DIP1 (q.v.Macular dystrophy, atypical vitelliform -?16p ( F ) = Vasopressinchr. 4 (REa) = Wilms tumor/aniridia/gonadoblastoma/retardation -llp1305-pl306 (Ch) = Tryptophanyl-tRNA synthetase -14q21-qter ( S ) = Waardenburq syndrome-1 -(39~334: ?linked to ABO) (F) = Xg blood group (Xp22.3; linked to STS) ( F ) = Kell blood group precursor (Xp22.3: linked to Xg) ( F ) = Xeroderma pigmentosum A complementation -Iq ( S ) = x-ray sensitivity -?13q14 (Ch) Four Lepore approach)(AAS) I I. GENE MAP OF THE AUTOSOMES", "latex": null, "type": "figure"}, "FIGREF12": {"text": "blood group 111162) F -?same as Scianna cen-PGM1-@8cM-CB-UMPK (F)C8 (beta polypeptide) (12096) F ~ lp32 (distal to PGM1) Uridine monophosphate kinase (19171) S, R lp34 Adenylate kinase-2, mitochondria1 (103021 S , F, R lp22.1 Phosphoglucomutase-1 (17190) F , S, R lpter-lp23 (L)Alcohol dehydrogenase (10372) S -?control of expression (M. Smith, heavy chain (13477) REa, REbpresumably pseudogene (also x et al.lq (close to Fy) Cataract, zonular pulverulent (11620) F lql2-lqter (P)Oncogene sloan-Ketterinq, SK, chicken virus (16478) REa (=DlS3) lp2l-lqter Actin, skeletal muscle alpha chains (102611 REa (I)lq42: lq21-lq31 Acid beta-glucosidase (glucocerebrosidase) (23080)s PKOX. IP O r (P)C-reactive protein (12326) REa lq12-q21 [distal to lqh) D u f f y blood group (11070) F, FC (p)C8 (alpha-gamma polypeptide) (12095) F h o t CloSelY linked Amylase, salivary (10470) F, A, R E a J M u l t i p l e genes 1 qh Satellite DNA I11 (D1Z1) (12637) A (P)Amyloid F (10475) REa (about 15 CM) Charcot-Marie-Tooth disease, slow nerve conduction type (11820) F (P)HISTONE CLUSTER B (H3,H4) (14278, 14275) REa,A lq21-lq23 Uridyl diphosphate glucose pyrophosphorylase-1 (19175) S , R 1q22 (PtAdenovirus-12 chromosome modification site-18 (10294) Methyltetrahydrofolate: L-homocysteine S-methyltransferase (tetrahydroptecoyl-glutamate methyltransfecase) (15657) S lp22.1-qter (PISuccinate dehydrogenase ( 1 of 2 polypeptides) (18547) S lcen-lq32 (P)Phosphofructokinase, muscle type (23280) S I \u00b6 (P)Xeroderma pigmentosum A (27870) S lq31-lq321 (L)Microcephaly, true (25120) Ch (P)Uroporphyrinogen decarboxylase (17610) S In addition: 2 anonymous DNA segments, 5 O'Farrell protein spots, and 2 antigens defined by monoclonal antibodies (MSK1, 15801: MKS2, 15802).", "latex": null, "type": "figure"}, "FIGREF13": {"text": "on right: Male genetic map of chromosome 1 (intervals measured in centimorgans). On left: map of physical assignments. (From Sherman, King, Robson and Yee. Ann. Hum. Genet. 48: 243-251, 1984.) POMC is the precursor f o r 7 peptide hormones as indicated here: Aryl hydrocarbon hydroxylase (10833) S (L)Aniridia (10620) F (L)Coloboma of iris (12020) Ch iL)Acrokeratoelastoidosis 110185) F [?linked to ACP1, J k , IGKC) Acid phosphatase-1 (17150) D, S Proopiomelanocortin (17683) REa Malate dehydrogenase, soluble (154201 s (P)Galactose enzyme activator (13703) S (P)Imrnunoglobulin heavy chain attachment site (14710) S (P)Acetylcholinesterase regulator, o r derepressor (10065) 0 2q23 Collagen I11 (alpha-l)(12018) REa, A 2p23-2q323 Adenosine deaminase complexing protein-2 (10272) S 2p12I2p11.2 by IMMUNOGLOBULIN KAPPA LIGHT CHAIN GENE FAMILY (Km: Inv) A, REa high resolution in situ mapping) Order: cen-V-J-C-ter 1P)Uridyl diphosphate glucose pyrophosphorylase-2 (19176) S Variable region of kappa light chain (many genes) (14698) J region of kappa light chain (several genes) (14697) constant region of kappa light chain (14720) cataract, anterior polar (11565) FC (see 14q24) 2p23-qter (L)Interferon-l (Ifunction in relation to IFF: not structural) (see 14757) S 243 6-2q37 Glucagon (13803) REa, A 2431-2qter (P)Elastin (130161 A Fibronectin-1 (13560) S (prob. structural gene; see chr. 8, 11) (L)collagen V (12019) REa In addition: 2 anonymous DNA segments (HGM 7) and 1 surface polypeptide (18561). orotate phosphoribosyltransferase -OMP decarboxylase (25892) ( s ) (P)Melanoma-associated antigen p97 (15575) S 3q23-3qter Transferrin receptor (19001) s, H, m a J ?related o r identical (P)ceruloplasmin (11770) F, H (m. (P)Alpha-2Hs-glycoprotein ( 1 3 8 6 8 ) F** (PITemperature sensitive (tsAF8) complement (11695) S (P,I)Herpes virus sensitivity (14245) S (see chr. 11) ?lpll.l(Or 7~1 3 ) (LIGreig craniopolysyndactyly syndrome (17570) Ch In addition: 4 anonymous DNA segments (HGM 7) *See Section I, B for definition. **Probably order = cen-TF-CHEl-A2HS chromosome NO. 4 (L)Alpha-fucosiaase-Z (13682) F (linked to PLG: lod 7.37, male theta 0.12) (L)Plasminogen", "latex": null, "type": "figure"}, "FIGREF14": {"text": "Linked to MNSs),4qZ Fibrinogen, gamma chain (13485) F, REa, H, RE, D (P)Temperature sensitivity complementation, ts13 (18732) S (P)Quinoid dihydropteridine reductase (26163) S (p)Leukocyte antigen gKOUp five (LAGS) (15145) S (P)Alcohol dehydrogenase, class 111 (ADH chi: ADHX) (10371) S alpha, beta and gamma 4q21-4qter (P)Alcohol dehydrogenase, class I (10370) REa (cluster Of ADH1, ADH2, ADH3 10Cl determining chains) 4q21-4qter (P)Epidermal growth factor (13153) REa 4q26-4q28 (P)T-cell growth factor (interleukin-2) (14768) REa (P)oncogene R A F~ (see 16476) REapseudogene In addition: 3 anonymous DNA segments and 1 antigen defined by a monoclonal (HGM 7 ) . Possible order: PLG -CEN -GC -DGI -Ss -MN -FGG Springer-verlag: J. b W. Bodmer, Immunoloqy Today, I 2~ 1-t D x~ , DCaIJCP I* -5 : 251-254, 1984.) Fig. 78 below shows the map as / = D . I .", "latex": null, "type": "figure"}, "FIGREF15": {"text": "From Dana and Wasmuth, Molec. Cell Biol. 2:1226, 1982. Ideogram of human chromosome 5 showing provisional regional assignments f o r the leus, hexB, emtB and chr genes. (Order On 5x7: CentKOmere-LARS-HEXB-EMTB-FMS-CHR-ter, clotting factor XII (Hageman factor) (23400) D 6p22 (distal to HLA) (P)Clotting factor XIII, A component (13457) F (male theta. 17 VS. HLA) 6p21.3 MAJOR HISTOCOMPATIBILITY COMPLEX (MHC)F, S , A, RE, Ch Fig. 7?. shows the revised nomenclature for the HLA-D (class 11) loci, as Set by 9th GLO HLA C4A,C4B,C2,81 HLA HLA HLA Histocompatibility Workshop (1984). discussed under the old nomenclature as follows: HLA-A 114280), HLA-B (142831, HLA-C (14284), HLA-D (14285), HLA-DR (14286). HLA-DR2 (14287), HLA-SB (14288). HLA-MT (14289). HLA-DC (14688). Also see HLA-D gamma (14279) on chr. 5. recombination with DQ hut physical distance by molecular studies about same as DQ-to-DR. Recombinational hotspots probably exist within DQ subregion and between HLA-A and HLA-C D P r l -D P r 6 D O w I I Y 6 I I Y T I I D C I DRI-DRWl4 which the molecular data Suggest are as close as DPWLIYBZIT.Z~IDC~ ORW 52", "latex": null, "type": "figure"}, "FIGREF16": {"text": "21700) F, LD -2% recomb. with HLA-B' complement component-4F. or C4B (12082) F, H -1Okb from C4S Complement component-4s. O K C4A (12081)F. H (?on HLA-B side of C4B) /B segment (P)Blastogenic response to synthetic polypeptides (14695, 14696) F In B/D segment (P)Blastogenic response to synthetic polypeptides (14681, 14682) F bp23-6q12(prob. close to HLA) Phosphoglycerate kinase, testicular: PGKA o r PGK2 (17227) REa, H (L)Ragweed sensitivity (17945) F (P)Immune suppression (IS) (14685) H (homologous to T region gene of mouse) Insulin dependent diabetes mellitus (22210) F, LD (LIManic-depressive illness (12548) F (L)Pepsinogen (16970) F, H (L)Paget disease of bone (16725) F (L)Laryngeal adductor paralysis (15027) F (P)Plasminogen activator (17337) S (P)Monkey RBC receptor (15805) S (1)Adenosine deaminase complexing protein-1 (10271) S U -A Baboon M7 virus replication, BEVI (10918) S hu-DIW (P)Argininosuccinate synthetase pseudogene-2 (10784) REa (Others on 8 O K more other chr. incl. X and perhaps Y) 9 anonvmous DNA sesments. 1 antiqen defined bv a monoclonal. Olaisen et al., 1983). *Intervals in CM estimated from linkage disequilibrium: D-0.44-BF-0.04-C4-0.ll-C2-O.lZ-B \"Prob. order (Dupont, 11/13/84): DR...CZ-BF-C4A-CA21HA-C4B-CA21HB....B.", "latex": null, "type": "figure"}, "FIGREF17": {"text": "Gene map of ChKOmOSOme 6. Recombination frequencies are for males. FromWeitkamp and L a m , H G M~, cytogenet. cell Genet. 32:133, 1982.  (Klouda et al. ( J . Med. Genet. 19: 337-341, 1980)  placed CAHl more remote from HLA-B, possibly outside the HLA complex, and close to DR.cell antigen receptor, beta subunit(18693)REa, A (PIGamma-glutamylcylotransferase (13717) s (P)Argininosuccinate lyase (20790) S Phosphoserine phosphatase (17248) S Biliverdin reductase (10975) s Uridine DhosDhorvlase 119173) LIGreigpolysyndactyly craniofacial dysmorphism syndrome (17570) Ch 7p22-7q22 Malate dehydrogenase, mitochondrial (15410) S 7pl3-7p22 ( ?p21-p22) Epidermal growth factor receptor (same as S7) (13155) s 7pter-7q22 Oncogene ERBB (19014) REa (same as EGFR?Nonhistone chromosomal protein-1 (11887) S(P)Growth rate controlling factor-1 (13922) S (L)Diaphorase-2 (12587) S (L)colton blood group (11045) D (but see Chr. 2) 7pll-7qll (P)Asparagine synthetase (10837) s 77p (L)Goldenhar syndrome (14140) Ch In addition: 5 anonymous DNA segments, 1 surface antigen (18552), and 2 O'Farrell protein spots (HGM 7) -like globin genes. The top line shows the w1 relative locations of the five functional beta-like globin genes and'the two beta-like pseudogenes. The bottom line shows the map of the four functional Dirmcth ot trmuriptlaralpha-like globin genes and the alpha-globin pseudogene \"psi alpha 1 : ?he mRNA coding sequences are designated by filled rectangles. From Proudfoot, et al.: Science 209: 1329, 1980.I I I I I , I l l I I I I I l I I l l I P 0rd. d. r 01 rtlrition In ontmny -The coding (shaded) and noncoding segments of the alpha and beta globin genes.(From  Proudfoot et al., Science 209: 1329", "latex": null, "type": "figure"}, "FIGREF18": {"text": "111: MUTATIONS IN B-THALASSEMIAS: Total number = 35 (Dec.cleavage t polyadenylation mutants I 0 )", "latex": null, "type": "figure"}, "FIGREF19": {"text": "courtesy of s.Antonarakis, NOV., 1984    8 LINKAGE MAP OF CHROMOSOME l l p .parotid salivary protein (pr)(16879)    Parotid acidic protein (pal(16873)    7 (C, F, LD) Double band parotid salivary protein (&) Parotid salivary glycoprotein (Gl) (16884) -Linkage disequilibrium Salivary protein Peprob. closely linked to Pa Probable order: Pa -Pr -Db -~1 PIF (parotid isoelectric focusing) protein (16872)(Ps and PIF closer to G1 and Db than PT or pa) Parotid middle band protein (Pm) (16878) linked to above five loci Parotid size variant (Psi (168811 Parotid basic protein IPb) 116875) linkage unknown Post-parotid basic protein (PPb) (16876) CON1 (16887)closely linked to Ps Sequence (AJHG a: 52, CON2 (16888)closely linked to PmF 1984): Ps-Pr-Pm-G1-Db. Salivary protein Poprob. closely linked to CON2 (16877) I . l ? i m r F * LD) (P)Methioninyl-tRNA synthetase (15656) S (P)Alpha-glycerophosphate dehydrogenase (13842) s 12pt er-12412 Branched chain amino acid aminotransferase-l(ll352) S 12P (P)Aromatic alpha-keto acid reductase (10792) S 12pter-12q14 (P)Oncogene INTl (murine mammary cancer virus) gamma or immune type (14757) S, A (3 introns: IFF, IFL none) 12q24.1 (P)Phenylalanine hydroxylase (26160) REa, A (L)Triosephosphate isomerase-2 119046) S ?12pl2.1,7?12q24.2 Oncogene ras2 (KRAS2): Kirsten rat sarcoma virus 119007) S (L)Lactate dehydrogenase c (150151 H (L)Human leukocyte antigen: MIC3 (Idistinct from S 8 ) 114303) S (P)Elastase-l 113012) REa (PIuv-damage, excision repair of (xP complementation group I) (19206) s ~l s o : 3 DNA segments, 1 surface antigen (185561, 3 antigens defined by monoclonals, 3 O'Farrell protein spots (HGM7). *Probable order: 12pter-TPI-GAPD-LDHB-ENO2-CeIl-SHMT-PEPB-12qter. LIDubin-Johnson syndrome (23750) LD (wit'h factor VII deficiency) 113q34 (L)Carotid body tumor (168001 F (?linked to faCtorS VII and XI 13ql4-13431 (L)Letterer-Siwe disease (24640) Ch (P)uv-damage, excision repair of (Xp complementation group 11 (19206) S (P)collagen Iv alpha-1 chain (12013) S In addition: 7 anonymous DNA segments (HGM 7).", "latex": null, "type": "figure"}, "FIGREF20": {"text": "S , D (p)Oncogene FOS: FBJ murine osteosarcoma virus (16481) REa, A Tryptophanyl-tRNA synthetase (19105) S (P)External membrane protein-195 (13374) s Creatine kinase, brain type (12328) S (P)Phosphoribosylglycineamide formyltransferase (17246) S 7-11 multifunctional (P)Phosphoribosyl formylglycinamidine synthetase (10258) S protein involved (P)ESteraSe activator (13325) s in de novo purine synthesis (L)Spherocytosis, Denver type (18290) F (L)T-cell idiotypic receptor for MHC antigens (18688) H (L)Cataract, anterior polar (11565) Fc (see 2~2 5 ) (P)Temperature sensitivity complementation, K12 (18731) S Protease inhibitor (PI; alpha-1-antitrypsin) (10740) F, S DNA segment 014.51 (10775) REa, A (2 other anonymous DNA segments -HGM7) IMMUNOGLOBULIN HEAVY CHAIN GENE FAMILY REa, A ** Variable region genes (about 250) (14707) D (for diversity) region genes (many) (14691) J (for joining) region genes (more than 4) (14701) constant region of heavy chain of IgMl (14702) Constant region of heavy chain of IGM2 (14703) constant region of heavy chain of IqD (14717) Constant region of heavy chain of IgG2 (14711) constant region of heavy chain of IgG4 ( 1 4 7 1 3 ) s 5'-G2-17kb-G4 -3' constant region of heavy chain of IgG3 (14712) close linkage known constant region of heavy chain of IgGl (14710)?from Lepore-like (1 4q32.33-14qter) Prob. orientation cen-P1-Dl4sl-i~~~constant region of heavy chain of IgE (14718) myeloma protein -1GHV-ter (3' centromeric: constant region of heavy chain of IgEPl (14713) IgEP2 on chr. 9 5 ' , telomeric: IgM constant region of heavy chain of IgAl (14690) telomeric to IgG). Constant region of heavy chain of 19A2 (14700) \"See next page. **A Tunisian deletion indicates order: -300: 760, 1982). 5' -EZ -EI -~3 -3' (Nishida et al., PNAS 79: 3833, 1982: E3 = Ipseudogene). Following information from J. J. Johnson and L. L. Cavalll-Sforza (Stanford Univ., NOY., 1 9 8 3 : -ja(qter)---v--(7cM)--~-4--8kb --mu--5kb--delta--?--gamma-3--26kb--gamma-l--l9kb--pseudo-epsilon-l(pseudo-epsilon-2 on chr. 9)--13kb--alpha-l--?-gamma-2--18kb--gamma-4--23kb--epsil0n--lOkb--alpha-2----3~(centromere).", "latex": null, "type": "figure"}, "FIGREF21": {"text": "Map of chromosome 19 syntenic group with distances in percentage male recombination. From Gedde-Dahl et al., Hum. Genet. 67: 181deaminase (10270) S, D, REa 20cen-20q131 S-adenosylhomocysteine hydrolase (18089) s (P)GfOwth hormone releasing factor (sornatocrinin) (13919) REa, REb (P)Vasopressin (19234) REa 1P)Desmosterol-to-cholesterol enzyme IDCE) 112565) F 20q12-20q13 Protooncogene % IRous sarcoma) (19003) REa, A (P1Neuraminidase and beta-galactosidase expression (25654) S In addition: 4 anonymous DNA segments (HGM 7). LIBeta-amino acids, renal transport of (10966) D (L)Beta-adrenergic stimulation, response to ( -L-iduronidase (25280) S , D 722q11.12(on Phl) IMMUNOGLOBULIN LAMBDA LIGHT CHAIN GENE FAMILY REa, A order 5 ' to 3': Variable region of lambda light chains (many genes) (14724) Cen-V-C-ter J region of lambda light chains (several genes) (14723) constant region of lambda light chains (14722) 22q11.3 (distal t o lambda) Chronic myeloid leukemia (15141) Ch [Ph1=t(9:22)(q34.1;qll.21) N-acetyl-alpha-D-galactosaminidase (alpha-galactosidase B ) (10417) S", "latex": null, "type": "figure"}, "FIGREF22": {"text": "The lambda constant region genes are 6 in number located in a 30 kb segment: 3 of them correspond to 3 of the 4 known nonallelic lambda constant chains, At least 3 other lambda constant genes have not been positioned. One of these presumably has the Kern(+)Oz(-) characteristic. The amino acid differences of these nonallelic forms are known. IHieter et al., Nature 294:536-540, 1981.) Fig. 14. From Jeffries et al., Nucl. Acids Res. 12: 3235, 1984. * See Section I, B f o r definitions of v, c, m, 1.", "latex": null, "type": "figure"}, "FIGREF23": {"text": "Linkage L-J---J m * o a 0 7 ,~~ 2~~0 9 Xo1072", "latex": null, "type": "figure"}, "TABREF0": {"text": "Number of loci assigned at each of the seven human gene mapping workshops", "latex": null, "type": "table"}, "TABREF2": {"text": "(REa) = Ceruloplasmin -(chr. 3; linked to TF) (F)", "latex": null, "type": "table"}, "TABREF3": {"text": "= Centric heterochromatic segment, long arm, chr. 9", "latex": null, "type": "table"}, "TABREF4": {"text": ")", "latex": null, "type": "table", "html": "<html><body><table><tr><td>Mutant Class I, </td><td>Nonfunctional mRNA ( A </td><td>\u00a0</td><td>Direct Detection </td></tr><tr><td>a. </td><td>Nonsense mutants: </td><td>\u00a0</td><td>\u00a0</td></tr><tr><td>1)codon 17 (A-T) </td><td>0 </td><td>Chinese </td><td>Oligonucleotide </td></tr><tr><td>\u00a0</td><td>2)codon 39 IC-T) </td><td>0 </td><td>Mediterranean </td><td>Oligonucleotide </td></tr><tr><td>\u00a0</td><td>3)codon 15 (G-A) </td><td>0 </td><td>As. Indian </td><td>Oligonucleotide </td></tr><tr><td>\u00a0</td><td>lltcondon 121 (G-T) </td><td>U </td><td>Polish </td><td>ECOR I </td></tr><tr><td>b. </td><td>Fcameshift mutants: </td><td>\u00a0</td><td>\u00a0</td></tr><tr><td>4)-2 codon 8 </td><td>0 </td><td>Turkish </td><td>01 igonucleotide </td></tr><tr><td>\u00a0</td><td>5 ) - 1 codon 18 </td><td>0 </td><td>As. Indian </td><td>Oligonucleotide </td></tr><tr><td>\u00a0</td><td>6)-1 codon 44 </td><td>0 </td><td>Kurdish </td><td>Oligonucleotide </td></tr><tr><td>\u00a0</td><td>7)tl codons 8/9 </td><td>0 </td><td>As. Indian </td><td>Oligonucleotide </td></tr><tr><td>\u00a0</td><td>81-4 codons 41/42 </td><td>0 </td><td>AS. Indian </td><td>Oligonucleotide </td></tr><tr><td>\u00a0</td><td>9)-1 codon 6 </td><td>0 </td><td>Mediterranean </td><td>MSt I1 </td></tr><tr><td>11. </td><td>1O)tl codons 71/72 RNA Processing mutants ( 0 ) splice junction changes: </td><td>0 </td><td>Chinese </td><td>Oligonucleotide </td></tr><tr><td>a. </td><td>\u00a0</td><td>\u00a0</td><td>\u00a0</td></tr><tr><td>\u00a0</td><td>1)IVS-1 position 1 (G-A) </td><td>0 </td><td>Mediterranean </td><td>Oligonucleotide </td></tr><tr><td>\u00a0</td><td>2)Ivs-1 position 1 </td><td>(G-T) 0 </td><td>AS. Indian </td><td>Oligonucleotide </td></tr><tr><td>\u00a0</td><td>3lIVS-2 position 1 (G-A) </td><td>U </td><td>Mediterranean </td><td>Hph I </td></tr><tr><td>\u00a0</td><td>4)IVS-1 3'-end -25 bp </td><td>0 </td><td>As. Indian </td><td>FnU 4H </td></tr><tr><td>\u00a0</td><td>5)IVS-2 3'-end (A-G) </td><td>0 </td><td>Am. Black </td><td>Oligonucleotide </td></tr><tr><td>\u00a0</td><td>17)IVS-1 3'-end -17 bp consensus changes: </td><td>U </td><td>Kuwaiti </td><td>FnU 4H </td></tr><tr><td>b. </td><td>\u00a0</td><td>\u00a0</td><td>\u00a0</td></tr><tr><td>\u00a0</td><td>6)IVS-1 position 5 </td><td>(G-Ct t </td><td>Indian </td><td>Oligonucleotide </td></tr><tr><td>\u00a0</td><td>7)IVS-1 position 6 </td><td>IT-Cl t </td><td>Mediterranean </td><td>Oligonucleotide </td></tr><tr><td>\u00a0</td><td>16lIVS-1 position 5 (6-TI </td><td>0 </td><td>Mediterranean </td><td>Oligonucleotide </td></tr><tr><td>C. </td><td>Internal IVS changes: </td><td>\u00a0</td><td>\u00a0</td></tr><tr><td>8)IVS-1 position 110 fG-A)t </td><td>Mediterranean </td><td>Oligonucleotide </td></tr><tr><td>\u00a0</td><td>9)IVS-1 </td><td>position 705 IT-G)t </td><td>Mediterranean </td><td>Oligonucleotide </td></tr><tr><td>\u00a0</td><td>IO)IVS-2 </td><td>position 745 (C-G)t </td><td>Mediterranean </td><td>RSa I </td></tr><tr><td>\u00a0</td><td>11)IVS-2 position 654 (C-TI0 (T-GI? coding regions substitutions </td><td>Chinese </td><td>Oligonucleotide </td></tr><tr><td>\u00a0</td><td>15)IVS-1 position 116 affecting processing: </td><td>Mediterranean </td><td>Mae I </td></tr><tr><td>d. </td><td>\u00a0</td><td>\u00a0</td></tr><tr><td>12)codon 26 (G-A) </td><td>E </td><td>S.E. Asian </td><td>HbE </td></tr><tr><td>\u00a0</td><td>13)codon 24 IT-A) </td><td>t </td><td>Am. lack </td><td>oligonucleotide </td></tr><tr><td>\u00a0</td><td>14)codon 27 (G-T) </td><td>KnosSoS </td><td>Mediterranean </td><td>Hb KnOSSoS </td></tr><tr><td>111. </td><td>Transcriptional mutants ( b </td><td>\u00a0</td><td>\u00a0</td></tr><tr><td>\u00a0</td><td>1)-88 C-T </td><td>t </td><td>Am. Black </td><td>Oligonucleotide </td></tr><tr><td>\u00a0</td><td>21-67 C-G </td><td>t </td><td>Mediterranean </td><td>AVC I1 </td></tr><tr><td>\u00a0</td><td>3)-28 A-C </td><td>t </td><td>Kurdish </td><td>Oligonucleotide </td></tr><tr><td>\u00a0</td><td>41-20 A-G </td><td>t </td><td>Chinese </td><td>Oligonucleotide oligonucleotide </td></tr><tr><td>\u00a0</td><td>5)-29 A-G </td><td>t </td><td>Am. Black </td><td>\u00a0</td></tr><tr><td>\u00a0</td><td>6)-31 A-G </td><td>+ </td><td>Japanese </td><td>Oligonucleotide </td></tr><tr><td>Iv. </td><td>RNA cleavage t </td><td>polyadenylation mutants I 0 </td><td>\u00a0</td></tr><tr><td>1)AATAAA -to- AACAAA </td><td>+ </td><td>Am. Black </td><td>Oligonucleotide </td></tr></table></body></html>"}, "TABREF5": {"text": "Fy, Pep C. ( F r o m Rao et al., @. 2.Hum. Genet. 31: 680-696, 1979.1", "latex": null, "type": "table"}, "TABREF8": {"text": "", "latex": null, "type": "table"}, "TABREF10": {"text": "Ribosomal RNA (18045) ALentil agglutinin binding (LCH) (15102) S Nucleoside phosphorylase", "latex": null, "type": "table"}, "TABREF11": {"text": "Lefranc et al., Nature H I P E R V I R I M L E i h G l avian erythroblastic leukemia virus, ERBA (19012) REa (~K O X . to APL break 17q210-17q220 Adenovirus-12 chromosome modification site-17 (10297) v 17q2l.l) 17q210-17q220 Thymidine kinase-1 (18830) s, Ch, R, c Acid alpha-glucosidase (23230) s, A 17q23-17qter Peptidase E (17020) s (P)AldolaSe C (10387) REb (L)Creatine kinase, brain type (12328) s In addition: 1 anonymous DNA segment, 1 antigen defined by a monoclonal antibody, and 1 surface antigen (18557)(HGM 71 Ch In addition: 3 anonymous DNA segments (HGM 7). PlBeta-qlucuronidase, mouse, modifier of (23161) S (P)Baboon Ml virus receptor (?same as virus RD114 receptor) (10919) S (P)Coxsackie B3 virus susceptibility (12005) s 1P)Branched chain amino acid transaminase-2 (11353) S 19pter-19q13 (P)Lysosomal DNA-ase (12635) s C3-Le-DM-Se-Lu Lewis blood group (11110) F (linked to C31 Linked t o PEPD(@ 5cM) Myotonic dystrophy (16090) F (in c3 linkage group: SRO for C3, 19pter-19p13.2) Secretor (18210) F @13cM from c3 Apolipoprotein E 120776) F, REa (?close t o se) Order suggested by Eiberg Apolipoprotein C-I1 (20775) R E a , F, LD d(vtF) 1P)Apo~ipoprotein c-I (10771) REa LE-C3-DM-(Se-PEPD)-Lu. Lutheran blood group (11120) Order (Breslow, 1984): (\u20ac')Bombay phenotype (Hh) ( 2 1 1 1 0 ) z (v.F)* (20cM) et al. (1983):FHC-C3-APOE/APOC2. Linked to DM?(P)Neurofibromatosis (162201 F  19q13.32-19qter   Ferritin, light chain(13479)S, A 19q13.32-19qter CHORIONIC GONADOTROPIN, BETA CHAIN (at least 8 penes) (11886) REa, H Luteinizinq hormone, beta chain (15278) RE In addition: 3 anonymous DNA segments (HGM 7). *see section I,B for definition.", "latex": null, "type": "table"}, "TABREF13": {"text": "Number of loci identified mainly by mendelizing phenotypes* From McKusick: Mendelian Inheritance &Man, with unpublished additions 'Numbers in parentheses refer to loci not fully identified O K validated. \"Lehrbuch der Humangenetik (Munich: urban 6 Schwartzenberg, 1958). THE MORBID ANATOMY OF THE HUMAN GENOME 0sLamb.r 1. 1984 . Nwplam with rpectfic chromosomal . Malformation syndrome with change and/or relation I 0 oncogene Specc111c mfectmns wilh amormgenic Sandhaff diseayl to DHFR deficiency MPS VI I M a r~f e a~x", "latex": null, "type": "table"}}, "back_matter": [{"text": "9pter-9q12 9pter-9q12 9pter-9q12 9~13-9p24 9pl3-9p22 9~13-9p21 (L) Fibronectin (13560) S (?concerned with expression on cell surface) (P)Spherocytosis (18290) F, Ch (linkage with t8:12 and t3:8; see chr. 14) (P) Clotting factor VII expression (13445) Fragile site 8q22.3, folic acid type (L)Neoplastic lymphopro~iferation-1 (16184) Ch (P) Thyroglobulin (18845) ( (e.g., 15125, 15126, 15127, 18554) . 29 antigens, not necessarily all separate and different, defined by monoclonal antibodies (e.g., 14304, 15806, 15807) , and 1 O'Farrell protein spot (HGM 7). *By in situ hybridization to meiotic pachytene chis. (Chaganti, 19841 . **See Mendelian Inheritance * _ I M a n , 6th ed., 1982) for amino acid substitutions in gamma, delta and beta variants and for molecular changes in deletion and non deletion forms of beta-thalassemia. The vcm -", "cite_spans": [{"start": 63, "end": 66, "text": "(L)", "ref_id": null}, {"start": 208, "end": 211, "text": "(P)", "ref_id": null}, {"start": 335, "end": 338, "text": "(P)", "ref_id": null}, {"start": 363, "end": 397, "text": "(e.g., 15125, 15126, 15127, 18554)", "ref_id": null}, {"start": 490, "end": 517, "text": "(e.g., 14304, 15806, 15807)", "ref_id": null}, {"start": 611, "end": 627, "text": "(Chaganti, 19841", "ref_id": null}, {"start": 672, "end": 686, "text": "6th ed., 1982)", "ref_id": null}], "ref_spans": [], "section": "annex"}]}